Trump's coronavirus treatment plan for himself.
So trans doctor release his treatment course.
Following PCR confirmation of the president's diagnosis as a precautionary measure he had received an 8 gram dose of Regeneron Polyclonal antibody cocktail.
He completed the infusion without incident. edition the Polyclonal antibiotics the president has been taking zinc, vitamin d, Famoridine, melatonin and a daily aspirin.
Famoridine = antacid
Zinc/ vitamin D = supplements that can be used for covid, mixed result.
Aspirin = likely just taking it for primary prevention for coronary artery disease.
Melatonin = sleep aid
( as you can see, no Hydroxycloiquin so if it isn't good enough for the president, it isn't good enough for you and it doesn't work)
Polyclonal Antibody- so re&general created anybody's are proteins that attach to the virus and kill it.
(The data we have is pretty limited)
The company reported the data in the press release with a promise to publish the full results later. They come from the first 275 patience in an adaptive phase, 1/2/3 study testing, the treatment and an on hospitalized patients with a lab confirmed test of coved 19. Patients received a high dose 8 Grams or low dose of 2.4 grams of the treatment, REGN- COV2, in a single infusion alongside the standard of care or placebo with standard of care, more than half of the patients we're Hispanic (56%) , and (13%) percent are African American.
(If you don't know what a placebo is look it up)
And it's important to know that the demographics of those patients in the trial, because those aren't Trumps demographics.
And what they found was.
Before starting the study, patients were tested to see whether they can produce coven 19 fighting antibodies. About 45 percent of them already had made it those antibodies on their own, while 41 percent had not made enough anybody's to a log a reading. The cocktail seemed that to its best in the later group, with a satisfyingly significant effect on virus levels 7 days after treatment, compared it to the patients with a low dose or placebo, the company said in a statement Tuesday and the higher a patient's virus level, the greater their reductions.
Meaning , the effect was greater on patients that couldn't mount, a good enough antibody response on their own.
And that correlated clinically to a reduction in symptom time.
38 days plasebo and between 2-8 days in the antibody group, depending on the dosage.
